leisure time -WSS

leisure time

author：Wikipedia 2025-09-27 19:28:07 - browse：63369

Sarepta - Cambridge -AP — Kristoffer Tripplaar/Sipa via AP

To hear Sarepta CEO Doug Ingram tell it, the results Monday afternoon from a large trial of its gene therapy for Duchenne muscular dystrophy marked a clear medical breakthrough. “A massive win,” he told investors, that could lead to its approval for all patients with the fatal muscle-wasting disease regardless of age.

And yet the rest of the Duchenne community was more cautious in its enthusiasm. The study — the most rigorous test to date of a technology 30 years in the making — had technically failed, as so many had before it.

“It’s extremely frustrating,” said John Brandsema, a pediatric neurologist at Children’s Hospital of Philadelphia who worked on the study. “When you spend decades trying to bring therapies into the clinic for something so severe and just keep missing over and over again.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： How a key Senate committee is planning to regulate PBMs

hotspot

WSS

Readout LOUD podcast: How biotech is using artificial intelligence

To avoid data mishandling cases, universities eye AI and other tools

What should King Charles tell the public about his cancer?

FAMU bans football players from facility after release of rap video shot in team's locker room

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

FDA approves first blood sugar monitor without finger pricks

focus

leisure time

Wikipedia

The cancer drug shortage isn’t new — and neither are the solutions

Vaccine advisory panel ACIP left half staffed by HHS

State Dept. review finds Biden bears some blame for Afghanistan failures

Burning questions about Delta and the next phase of the Covid pandemic

Continuity nursing helped my family in our darkest PICU moments

Thousands protest mob assault of women who were paraded naked in remote Indian border state

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Transgender women dream of pregnancy via uterus transplants

Medicare proposal to cover medical devices draws a mixed reaction

FAMU bans football players from facility after release of rap video shot in team's locker room

leisure time

FAMU bans football players from facility after release of rap video shot in team's locker room

Malaysia cuts short music fest after British band slams anti

Readout LOUD podcast: How biotech is using artificial intelligence

New requirements coming in 2024 for Americans traveling to Europe

Severe heat forecast: Where scorching temperatures will persist over the next week

Industry veterans launch new biotech VC with $310M

hotspot

focus

leisure time

hotspot